Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 7 Results

Title
Intervention Indication Therapeutic Area Year Actions
Acalabrutinib for treating relapsed or refractory mantle cell lymphoma Acalabrutinib (Calquence; ACP-196) Mantle cell lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Acalabrutinib with bendamustine and rituximab for treating previously untreated mantle cell lymphoma Acalabrutinib (Calquence; ACP-196) , Bendamustine (Treanda; EP-3102; Levact; Ribomustin; bendamustine hydrochloride monohydrate; bendamustine hydrochloride) , Rituximab (MabThera; Rituxan; RG 105) Mantle cell lymphoma Haematological Cancer and Lymphomas 2022 View  |  Download
KTE-C19 for relapsed or refractory mantle cell lymphoma Axicabtagene Ciloleucel (Yescarta; KTE-C19) Mantle cell lymphoma Haematological Cancer and Lymphomas 2017 View  |  Download
Pirtobrutinib for mantle cell lymphoma Pirtobrutinib (LY3527727; LOXO-305) Mantle cell lymphoma Haematological Cancer and Lymphomas 2021 View  |  Download
Pirtobrutinib for previously treated Bruton tyrosine kinase inhibitor naïve mantle cell lymphoma Pirtobrutinib (LY3527727; LOXO-305) Mantle cell lymphoma Haematological Cancer and Lymphomas 2024 View  |  Download
Venetoclax in addition to ibrutinib for relapsed mantle cell lymphoma – second-line and beyond Ibrutinib (Imbruvica) , Venetoclax (Venclyxto; ABT-199; Venclexta; GDC-0199) Mantle cell lymphoma Haematological Cancer and Lymphomas 2020 View  |  Download
Zanubrutinib for previously treated mantle cell lymphoma Zanubrutinib (BGB-3111; Brukinsa) Mantle cell lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications